XTL Biopharmaceuticals Ltd (XTLB)
2.61
+0.02
(+0.77%)
USD |
NASDAQ |
May 01, 16:00
2.51
-0.10
(-3.83%)
After-Hours: 20:00
XTL Biopharmaceuticals Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2014 | 0.309M |
| September 30, 2014 | 0.481M |
| June 30, 2014 | 0.595M |
| March 31, 2014 | 0.538M |
| December 31, 2013 | 0.317M |
| September 30, 2013 | 0.227M |
| June 30, 2013 | 0.495M |
| March 31, 2013 | 0.522M |
| December 31, 2012 | 4.283M |
| September 30, 2012 | 4.201M |
| Date | Value |
|---|---|
| June 30, 2012 | 3.799M |
| March 31, 2012 | 3.748M |
| December 31, 2011 | 1.744M |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | 1.473M |
| June 30, 2010 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | -- |
| BioLine Rx Ltd | 15.06M |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | 2.899M |